Biocon Limited has informed the Exchange regarding a press release dated July 03, 2023, titled "After Five Years of Successful Experience Internationally, Biocon Biologics Hulio�� Biosimilar to Humira��, Now Available in the United States".
Biocon Limited has informed the Exchange regarding a press release dated July 03, 2023, titled "After Five Years of Successful Experience Internationally, Biocon Biologics Hulio�� Biosimilar to Humira��, Now Available in the United States".